Insider · CIK 0002051489
Walbert Keli
Reports to the SEC for 3 companies · CAMBRIDGE, MA
Transactions
13
Companies
3
Filings
6
CIK
0002051489
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2026-09-24 | COAGHemab Therapeutics Holdings, Inc. · Stock Option (Right to Buy)A Award | — |
| 2026-05-21 | SPRBSPRUCE BIOSCIENCES, INC. · Stock Option (Right to Buy)A Award | — |
| 2026-05-14 | APLSApellis Pharmaceuticals, Inc.U Disposition from Tender | — |
| 2026-05-14 | APLSApellis Pharmaceuticals, Inc.D Disposition to Issuer | — |
| 2026-05-14 | APLSApellis Pharmaceuticals, Inc.D Disposition to Issuer | — |
| 2026-05-14 | APLSApellis Pharmaceuticals, Inc.D Disposition to Issuer | — |
| 2026-05-14 | APLSApellis Pharmaceuticals, Inc. · Stock Option (right to buy)D Disposition to Issuer | — |
| 2026-05-14 | APLSApellis Pharmaceuticals, Inc. · Stock Option (right to buy)D Disposition to Issuer | — |
| 2026-01-01 | APLSApellis Pharmaceuticals, Inc.A Award | — |
| 2026-01-01 | APLSApellis Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award | — |
| 2025-12-11 | SPRBSPRUCE BIOSCIENCES, INC. · Stock Option (Right to Buy)A Award | — |
| 2025-01-08 | APLSApellis Pharmaceuticals, Inc.A Award | — |
| 2025-01-08 | APLSApellis Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award | +$508K |
Recent filings
- 4Walbert Keli0001193125-26-402936SEC(opens sec.gov)
- 4Walbert Keli0002051489-26-000002SEC(opens sec.gov)
- 4Walbert Keli0001193125-26-224601SEC(opens sec.gov)
- 4Walbert Keli0001492422-26-000009SEC(opens sec.gov)
- 4Walbert Keli0002051489-25-000007SEC(opens sec.gov)
- 4Walbert Keli0001127602-25-001073SEC(opens sec.gov)
Companies
Address
C/O HEMAB THERAPEUTICS HOLDINGS, INC. 101 MAIN STREET, SUITE 1220
CAMBRIDGE, MA, 02142